XML 67 R44.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments - Warrant liability (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
Jun. 02, 2021
Jan. 28, 2021
Derivative warrant liability was valued based on significant inputs not observable in the market, which represents a Level 3      
Beginning balance $ 0    
Issuance of warrant 4,332    
(Decrease) increase in the fair value of the warrants (864)    
Reclassification of warrant liability to additional paid-in capital (3,468)    
Ending balance $ 0    
Common stock      
Financial Instruments      
Number of shares which may be purchased with warrants   467,500  
Exercise price of warrants (in dollars per share)   $ 2.10  
Quellis Biosciences, Inc | Series X redeemable convertible preferred stock      
Financial Instruments      
Number of shares which may be purchased with warrants     2,805
Exercise price of warrants (in dollars per share)     $ 341.70
Quellis Biosciences, Inc | Common stock      
Financial Instruments      
Number of shares which may be purchased with warrants     30,856
Exercise price of warrants (in dollars per share)     $ 2.10